Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Ribocure Pharmaceuticals AB

Clinicaltrial registered20 Oct 2026

Ribocure Pharmaceuticals AB

20 Oct 2026: Trial registered · RBD1119 in Coronary Artery Disease (CAD). Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
20 Oct 2026
Title
RBD1119 in Coronary Artery Disease (CAD)
Conditions
Stable Coronary Artery Disease
Phase
Phase 2
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Poland, Sweden
Country
Poland
Reference
NCT07884136
Location
Poland, Sweden
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Ribocure Pharmaceuticals AB

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Poland

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.